Nodal disease burden and outcome of medullary thyroid carcinoma.
By: Lindsey E Moses, Jamie R Oliver, Janine M Rotsides, Qianhui Shao, Kepal N Patel, Luc G T Morris, Babak Givi

Department of Otolaryngology, New York University, New York, NY, USA.
2020-03-15; doi: 10.1002/hed.26511
Abstract

Background

Medullary thyroid carcinoma (MTC) is a rare malignancy with high incidence of cervical lymph node (CLN) metastasis. We investigated the impact of nodal disease burden on survival.

Methods

We searched the National Cancer Database for MTC patients treated surgically. Impact of nodal metastasis on survival was analyzed using Cox univariable and multivariable regression.

Results

We identified 2627 patients from 2004 to 2015. Positive CLNs were identified in 1433 (54.5%), and 542 (20.6%) had >10 CLN+. Overall survival was 94.5% and 89.6% at 3 and 5 years. Patients with 11 to 20 CLN+ had significantly worse survival than patients with 1 to 10 CLN+ in univariable and multivariable analyses (HR = 3.56 (2.31-5.50) vs 2.26 (1.60-3.20); P < .0001). The ratio of positive to dissected CLN was associated with overall survival.

Conclusions

Higher burden of nodal disease is associated with worse survival in MTC. The number of positive nodes could be a valuable prognosticator in addition to the current staging system.



© 2020 Wiley Periodicals LLC.

PMID:33107153






Copyright 2026 InterMDnet | Privacy Policy | Disclaimer | System Requirements